[go: up one dir, main page]

Houdijk et al., 1986 - Google Patents

Subendothelial proteins and platelet adhesion. von Willebrand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of …

Houdijk et al., 1986

View PDF
Document ID
506199813304542875
Author
Houdijk W
De Groot P
Nievelstein P
Sakariassen K
Sixma J
Publication year
Publication venue
Arteriosclerosis: An Official Journal of the American Heart Association, Inc.

External Links

Snippet

Endothelial cell matrix contained von Willebrand factor (VWF), fibronectin, and thrombospondin. The role of these proteins in the adhesion of platelets was investigated by preincubation of the matrix with specific antibodies and subsequent perfusion with human …
Continue reading at www.ahajournals.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells

Similar Documents

Publication Publication Date Title
Houdijk et al. Subendothelial proteins and platelet adhesion. von Willebrand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of human vascular endothelial cells.
Ruan et al. Monoclonal Antibody to Human Platelet Glycoprotein I II. EFFECTS ON HUMAN PLATELET FUNCTION
Jaffe et al. Synthesis of fibronectin by cultured human endothelial cells.
Hantgan et al. Glycoprotein Ib, von Willebrand factor, and glycoprotein IIb: IIIa are all involved in platelet adhesion to fibrin in flowing whole blood
Hayman et al. Distribution of fetal bovine serum fibronectin and endogenous rat cell fibronectin in extracellular matrix.
Henrita van Zanten et al. Platelet adhesion to collagen type IV under flow conditions
Moake et al. Involvement of large plasma von Willebrand factor (vWF) multimers and unusually large vWF forms derived from endothelial cells in shear stress-induced platelet aggregation.
Stiko-Rahm et al. Secretion of plasminogen activator inhibitor-1 from cultured human umbilical vein endothelial cells is induced by very low density lipoprotein.
Houdijk et al. Fibronectin in artery subendothelium is important for platelet adhesion
Pommier et al. Plasma fibronectin enhances phagocytosis of opsonized particles by human peripheral blood monocytes.
Haynes et al. Measurement of an adhesion molecule as an indicator of inflammatory disease activity: Up‐regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis
Raugi et al. Thrombospondin: synthesis and secretion by cells in culture.
Sobel et al. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo.
DiMinno et al. A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder.
Green et al. Aggregation of macrophages and fibroblasts is inhibited by a monoclonal antibody to the hyaluronate receptor
Sreedhara et al. Uremic patients have decreased shear-induced platelet aggregation mediated by decreased availability of glycoprotein IIb-IIIa receptors
US4829000A (en) Reconstituted basement membrane complex with biological activity
Coller The effects of ristocetin and von Willebrand factor on platelet electrophoretic mobility
Kradin et al. Factor XIII A is synthesized and expressed on the surface of U937 cells and alveolar macrophages
de Groot et al. Perturbation of human endothelial cells by thrombin or PMA changes the reactivity of their extracellular matrix towards platelets.
Peters et al. Release of Soluble Fibronectin Containing an Extra Type III Domain (ED1) during Acute Pulmonary Injury Mediated by Oxidants or Leukocytes in ViV01-4
Baruch et al. Role of von Willebrand factor associated to extracellular matrices in platelet adhesion
Aggeler et al. Purification of plasma thromboplastin factor B (plasma thromboplastin component) and its identification as a beta2 globulin
Girma et al. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib
Cammarata et al. Identification of noncollagenous components of calf lens capsule: Evaluation of their adhesion‐promoting activity